Page 2945 - Markets News

Alembic Pharma zooms 20% as USFDA gives nod for anti-depression drug

The stock is locked in upper circuit of 20% at Rs 522 after the company received approval from the USFDA for its ANDA Bupropion hydrochloride tablets USP, 75 mg and 100 mg.

Nifty Consumption index nears record high; Nestle India shares cross Rs 10k

At 11:51 am; Nifty Consumption index was up 0.77% at 5,106.85, less than 1% away from its all-time high of 5,154 recorded on January 9, 2018 in intra-day trade.

D-Mart operator Avenue Supermarts' m-cap crosses Rs 1-trillion mark

The stock hit a new high of Rs 1,620, rallying 19% from its recent low of Rs 1,359 on May 23.

PSU banks extend gain; PNB, Corporation Bank up over 4%

At 11:01 am; Nifty PSU Bank index, the largest gainer among sectoral indices, was up 1.7%, rallied 6.5% in past four trading sessions, as compared to 2% rise in Nifty 50

Videocon case: Sebi can't demand Chanda Kochhar's resignation, says report

If found guilty of violating fair disclosure norms, Sebi can impose a penalty but cannot ask Chanda Kochhar to resign, according to the report

Weakness persists, banks drag

Bank, metal and oil and gas shares weak

Global stocks set to wobble after heated G7 and ahead of Trump-Kim summit

The S&P 500 futures were down 0.3 percent, while the New Zealand stocks were off 0.3 percent. Australian markets were closed for a holiday

Monsoon effect: Farm input companies seen improving performance

The consumption of agrochemicals in the domestic market remained subdued during the fourth quarter of 2017-18

Stock ideas for today by Prabhudas Lilladher: Buy JK Tyre, Ambuja Cements

Nifty outlook and few trading ideas by Vaishali Parekh, Research Analyst - Technical Research at Prabhudas Lilladher

Nifty outlook and top trading ideas by Devang Shah for today's trade

Short-term outlook for the market remains positive till Nifty trades above 10,417 levels

Street signs: MFs place contra bets in pharma, Biocon sees rise, and more

Shares of Avenue Supermarts get a lot of market attention as they have soared more than five times over their IPO price

Investor wealth of Rs 15.8 billion riding on stocks under Sebi lens

In the case of foreign investors, Rs 25.7 billion is riding on HEG, Rain Industries and Soril Holdings

Market mind: A pursa for mid-cap investors

The free fall (maybe on an after-thought one should call it a 'correction' in long-term investing interests) emphasises that most of us know when to buy; few know when to sell

We are underweight on India in our Asian funds, says Geoff Lewis

There appears to have been less selling pressure from domestic investors in equity mutual funds, he said

Sharp recovery ahead for SBI, Sun Pharma, Tata Motors, Apollo Hospitals

If things go as per plan, expect these sector leaders to post robust growth in revenues, margins and net profit in the current fiscal

India Inc raises Rs 672 billion by issuing shares to investors in FY18

The funds were mobilised for business expansion, refinancing of debt, working capital requirements and other general corporate purposes

6 of top-10 most valued cos add Rs 60,208cr in m-cap; RIL contributes most

The valuation of Infosys jumped Rs 8,627.3 crore to Rs 2,75,145.41 crore, and that of Tata Consultancy Services (TCS) surge

Domestic macro data like IIP, CPI and global cues to drive market this week

Experts said that the near-term market trend will be dictated by domestic macro data like IIP, CPI and WPI, movement of crude oil prices and currency (INR vs USD) and progress of monsoon.

Arbitration hearing starts in NSE-Singapore bourse case

Last month, the NSE had approached the high court, seeking an injunction against SGX

Tribunal order puts spotlight on demat share fraud

Company dematted shares in excess of paid-up capital and introduced them into the market